NCT00377117View on ClinicalTrials.gov

Diabetes Screening, Risk Management and Disease Management in a High-Risk Mental Health Population Part II

CompletedOBSERVATIONAL
Enrollment

39

Participants

Timeline

Start Date

May 31, 2006

Study Completion Date

July 31, 2007

Conditions
Diabetes MellitusSchizophreniaPsychotic Disorders
Interventions
PROCEDURE

Management

PROCEDURE

Screening

Trial Locations (1)

N6A 4H1

Regional Mental Health Care London, London

All Listed Sponsors
collaborator

Eli Lilly and Company

INDUSTRY

collaborator

St. Joseph's Health Care London

OTHER

lead

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

OTHER

NCT00377117 - Diabetes Screening, Risk Management and Disease Management in a High-Risk Mental Health Population Part II | Biotech Hunter | Biotech Hunter